LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
S. 822: Justice for All Reauthorizatio Act of 2013: Provisions regarding Debbie Smith DNA backlog.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Copyright/Patent/Trademark CPT
H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Medicare/Medicaid MMM
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY MUHLBERG | N/A |
Budget/Appropriations BUD
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Immigration IMM
S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Medical/Disease Research/Clinical Labs MED
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
| AMY MUHLBERG | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.